December 9, 2008 — ZURICH (Reuters) - Novartis AG's cancer drug Tasigna was effective and helped achieve rapid responses as an initial therapy in newly diagnosed patients with a life threatening form of leukemia, the company said.

November 18, 2008 — NEW YORK (Reuters Health) - Research from Italy provides new evidence that exposure to the industrial solvent benzene increases a person's risk of developing multiple myeloma.

September 4, 2008 — WASHINGTON (Reuters) - Cancer experts who probed every gene in tumors from two of the hardest-to-treat cancers found that cancer is much more complicated than anyone thought -- and say they found why a cure is so unlikely after a tumor has spread.